View in EDS

First-Line Therapy for Advanced Renal Cell Carcinoma: Score-Matched Analysis of Dual Combination Immunotherapy versus Combination of Tyrosine Kinase Inhibitors and Immunotherapy in the TOURS Multicenter Study.

Saved in:
Bibliographic Details
Title: First-Line Therapy for Advanced Renal Cell Carcinoma: Score-Matched Analysis of Dual Combination Immunotherapy versus Combination of Tyrosine Kinase Inhibitors and Immunotherapy in the TOURS Multicenter Study.
Authors: Watanabe H; Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu, 431-3192, Japan. urohiro@hama-med.ac.jp., Nakane K; Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan., Nukaya T; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan., Naiki T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Yasui T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Takahara K; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan., Koie T; Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan., Inamoto T; Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu, 431-3192, Japan., Miyake H; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Source: Targeted oncology [Target Oncol] 2026 May; Vol. 21 (3), pp. 399-410. Date of Electronic Publication: 2026 Apr 22.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1776-260X
DOI:10.1007/s11523-026-01219-y